Ayurveda-Based Integrative Management Of Diabetic Retinopathy

Clinical Evaluation Of Ayurveda- Based Integrative Management Of Diabetic Retinopathy - DRAIM

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/09/015683

Enrollment

Registered

2018-09-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes Health Condition 2: H352- Other non-diabetic proliferative retinopathy

Interventions

Intervention1: Nishoshiradi taila, Anutaila or Ksheerabala101 oil, Lodhravasadi Grutha, Nishakatakadi Kashayam, Kaalashakadi Kashayam, Vasaguduchyadi Kashayam.: -Shiroabhyanga (Head massage) for 20min

Eligibility

Inclusion criteria

Inclusion criteria: -Non insulin dependent diabetes mellitus -Mild to Moderate Diabetic Retinopathy

Exclusion criteria

Exclusion criteria: -Patients with H/O Previous treatment for diabetic retinopathy, including laser and Anti- VEGF drug. -Presence of severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy -Other ophthalmic conditions such as Cataract etc. -Presence of diabetic nephropathy or cardiovascular disease -Pregnancy or Lactation -HbA1C >10% -Statin Use

Design outcomes

Primary

Measure	Time frame
Significant decrease in the frequency and severity of manifestations of diabetic retinopathy(DR), including cotton wool spots, dot and blot hemorrhages and macular exudatesTimepoint: Assessment done at baseline and 6months with Optical Coherence Tomography(OCT) Fundus Photography(FP), Visual Acuity(V/A) and Visual Function Questionnaire(VFQ) will be done at baseline, three and six months.	—

Secondary

Measure	Time frame
-Significant reduction of macular thickness measured using OCT in patients with diabetic macular edema. -No significant loss of vision,i.e reduction of visual acuity by 2 lines or more on the LogMAR chart, not attributable to other visual disorders such as cataract. -Improvement or no worsening of visual function and quality of life at the end of the Study period.Timepoint: Assessment done at baseline and 6months with Optical Coherence Tomography(OCT) Fundus Photography(FP), Visual Acuity(V/A) and Visual Function Questionnaire(VFQ) will be done at baseline, three and six months.	—

Measure

Time frame

-Significant reduction of macular thickness measured using OCT in patients with diabetic macular edema. -No significant loss of vision,i.e reduction of visual acuity by 2 lines or more on the LogMAR chart, not attributable to other visual disorders such as cataract. -Improvement or no worsening of visual function and quality of life at the end of the Study period.Timepoint: Assessment done at baseline and 6months with Optical Coherence Tomography(OCT) Fundus Photography(FP), Visual Acuity(V/A) and Visual Function Questionnaire(VFQ) will be done at baseline, three and six months.

—

Countries

India

Contacts

Public ContactDr GG Gangadharan

Ramaiah Indic Specialty Ayurveda Restoration Hospital

msricaimresearch@gmail.com9448278900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026